Research Article

Blood Transfusions in Total Hip and Knee Arthroplasty: An Analysis of Outcomes

Table 2

The prevalence of selected comorbidities is listed in this table characterized by transfusion.

ComorbidityTransfusionNo transfusion value
(%) (%)

Myocardial infarction4,267 (4.25)15,235 (3.55)<0.001
Peripheral vascular disease2,446 (2.44)6,798 (1.58)<0.001
Cerebrovascular disease392 (0.39)842 (0.2)<0.001
Dementia176 (0.18)326 (0.08)<0.001
COPD15,420 (15.37)60,447 (14.07)<0.001
Rheumatic disease5,312 (5.29)15,411 (3.59)<0.001
Mild liver disease479 (0.48)858 (0.20)<0.001
Severe liver disease135 (0.13)127 (0.03)<0.001
Diabetes18,734 (18.67)73,690 (17.15)<0.001
Complicated diabetes1,561 (1.56)4,157 (0.97)<0.001
Renal disease92 (0.09)174 (0.04)<0.001
Cancer2,636 (2.63)6,702 (1.56)<0.001
Hypertension61,924 (61.71)262,215 (61.02)<0.001
Complicated hypertension6,753 (6.73)13,587 (3.16)<0.001
Pulmonary hypertension1,104 (1.10)2,137 (0.50)<0.001
Deficiency anemia35,186 (35.06)81,132 (18.88)<0.001
Pulmonary circulation disorder3,067 (3.06)7,103 (1.65)<0.001
Fluid and electrolyte disorders20,553 (20.48)48,526 (11.29)<0.001
Psychoses3,130 (3.12)9,583 (2.23)<0.001
Sleep apnea6,394 (6.37)37,852 (8.81)<0.001
Obesity15,545 (15.49)78,807 (18.34)<0.001